BATS BZX Real-Time Price
As of 2:36pm ET
| -0.63 / -0.76%|
The 8 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 120.00, with a high estimate of 136.00 and a low estimate of 83.00. The median estimate represents a +45.60% increase from the last price of 82.42.
The current consensus among 9 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.